Literature DB >> 32616527

Anti-C5 antibody treatment for delayed hemolytic transfusion reactions in sickle cell disease.

Aline Floch1, Alexandre Morel2, Fabian Zanchetta-Balint3, Catherine Cordonnier-Jourdin4, Slimane Allali5, Maximilien Grall6, Ghislaine Ithier7, Benjamin Carpentier8, Sadaf Pakdaman9, Jean-Claude Merle10, Radjiv Goulabchand11, Tackwa Khalifeh12, Ana Berceanu13, Cécile Helmer14, Christelle Chantalat-Auger15, Véronique Frémeaux-Bacchi16, Marc Michel17, Mariane de Montalembert5, Armand Mekontso-Dessap18, France Pirenne9, Anoosha Habibi3, Pablo Bartolucci19.   

Abstract

Keywords:  Delayed Hemolytic Transfusion Reaction with Hyperhemolysis; Hemoglobinopathies; Transfusion Medicine

Year:  2020        PMID： 32616527      PMCID： PMC7604638          DOI： 10.3324/haematol.2020.253856

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

1.  Eculizumab salvage therapy for delayed hemolysis transfusion reaction in sickle cell disease patients.

Authors:  Guillaume Dumas; Anoosha Habibi; Thierry Onimus; Jean-Claude Merle; Keyvan Razazi; Armand Mekontso Dessap; Frederic Galactéros; Marc Michel; Veronique Frémeaux Bacchi; France Noizat Pirenne; Pablo Bartolucci
Journal:  Blood       Date:  2016-01-12       Impact factor: 22.113

2.  Successful Outcome of Hyperhemolysis in Sickle Cell Disease following Multiple Lines of Treatment: The Role of Complement Inhibition.

Authors:  Efthymia Vlachaki; Eleni Gavriilaki; Katerina Kafantari; Despoina Adamidou; Dimitris Tsitsikas; Eleni Chasapopoulou; Achilles Anagnostopoulos; Apostolos Tsapas
Journal:  Hemoglobin       Date:  2019-01-09       Impact factor: 0.849

3.  Extracorporeal Life Support for Severe Acute Chest Syndrome in Adult Sickle Cell Disease: A Preliminary Report.

Authors:  Florence Boissier; François Bagate; Matthieu Schmidt; Vincent Labbé; Antoine Kimmoun; Muriel Fartoukh; Armand Mekontso Dessap
Journal:  Crit Care Med       Date:  2019-03       Impact factor: 7.598

4.  Intravascular hemolysis activates complement via cell-free heme and heme-loaded microvesicles.

Authors:  Nicolas S Merle; Anne Grunenwald; Helena Rajaratnam; Viviane Gnemmi; Marie Frimat; Marie-Lucile Figueres; Samantha Knockaert; Sanah Bouzekri; Dominique Charue; Remi Noe; Tania Robe-Rybkine; Marie Le-Hoang; Nathan Brinkman; Thomas Gentinetta; Monika Edler; Sara Petrillo; Emanuela Tolosano; Sylvia Miescher; Sylvain Le Jeune; Pascal Houillier; Sophie Chauvet; Marion Rabant; Jordan D Dimitrov; Veronique Fremeaux-Bacchi; Olivier P Blanc-Brude; Lubka T Roumenina
Journal:  JCI Insight       Date:  2018-06-21

5.  Complement activation during intravascular hemolysis: Implication for sickle cell disease and hemolytic transfusion reactions.

Authors:  N S Merle; I Boudhabhay; J Leon; V Fremeaux-Bacchi; L T Roumenina
Journal:  Transfus Clin Biol       Date:  2019-02-22       Impact factor: 1.406

6.  Delayed hemolytic transfusion reaction in children with sickle cell disease.

Authors:  Mariane de Montalembert; Marie-Dominique Dumont; Claire Heilbronner; Valentine Brousse; Oussama Charrara; Béatrice Pellegrino; Christophe Piguet; Valérie Soussan; France Noizat-Pirenne
Journal:  Haematologica       Date:  2011-02-17       Impact factor: 9.941

Review 7.  How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions.

Authors:  France Pirenne; Karina Yazdanbakhsh
Journal:  Blood       Date:  2018-05-03       Impact factor: 22.113

8.  Delayed hemolytic transfusion reaction in adult sickle-cell disease: presentations, outcomes, and treatments of 99 referral center episodes.

Authors:  Anoosha Habibi; Armand Mekontso-Dessap; Constance Guillaud; Marc Michel; Keyvan Razazi; Mehdi Khellaf; Btissam Chami; Dora Bachir; Claire Rieux; Giovanna Melica; Bertrand Godeau; Frédéric Galacteros; Pablo Bartolucci; France Pirenne
Journal:  Am J Hematol       Date:  2016-07-14       Impact factor: 10.047

9.  American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support.

Authors:  Stella T Chou; Mouaz Alsawas; Ross M Fasano; Joshua J Field; Jeanne E Hendrickson; Jo Howard; Michelle Kameka; Janet L Kwiatkowski; France Pirenne; Patricia A Shi; Sean R Stowell; Swee Lay Thein; Connie M Westhoff; Trisha E Wong; Elie A Akl
Journal:  Blood Adv       Date:  2020-01-28

10.  Contribution of alternative complement pathway to delayed hemolytic transfusion reaction in sickle cell disease.

Authors:  Satheesh Chonat; Maa-Ohui Quarmyne; Caroline M Bennett; Christina L Dean; Clinton H Joiner; Ross M Fasano; Sean R Stowell
Journal:  Haematologica       Date:  2018-05-24       Impact factor: 11.047
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.